Glenmede Trust’s Prothena Corp PRTA Stock Holding History

Glenmede Trust’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,069	Closed	-$246K	–	1349
2023 Q2	$246K	Hold	5,069	–	–	﹤0.01%	1042
2023 Q1	$246K	Sell	5,069 -323	-6%	-$17.1K	﹤0.01%	1047
2022 Q4	$325K	Buy	+5,392	New	+$316K	﹤0.01%	963
2016 Q3	–	Sell	-399	Closed	-$13K	–	2660
2016 Q2	$13K	Hold	399	–	–	﹤0.01%	2039
2016 Q1	$16K	Sell	399 -9,524	-96%	-$373K	﹤0.01%	1885
2015 Q4	$675K	Buy	9,923 +9,524	+2,387%	+$574K	﹤0.01%	836
2015 Q3	$18K	Hold	399	–	–	﹤0.01%	1930
2015 Q2	$21K	Sell	399 -121	-23%	-$4.78K	﹤0.01%	1895
2015 Q1	$19K	Hold	520	–	–	﹤0.01%	1961
2014 Q4	$10K	Hold	520	–	–	﹤0.01%	2212
2014 Q3	$10K	Hold	520	–	–	﹤0.01%	2119
2014 Q2	$10K	Hold	520	–	–	﹤0.01%	2044
2014 Q1	$19K	Hold	520	–	–	﹤0.01%	1899
2013 Q4	$13K	Buy	520 +121	+30%	+$3.04K	﹤0.01%	1929
2013 Q3	$8K	Hold	399	–	–	﹤0.01%	1971
2013 Q2	$5K	Buy	+399	New	+$3.71K	﹤0.01%	1998

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust's PRTA Position: Q3 2023 in Review

Glenmede Trust sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 5,069 shares — an estimated $246K sold.

Glenmede Trust first reported a position in PRTA in Q2 2013 and held it in 16 quarters. The position peaked at $675K in Q4 2015. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

Glenmede Trust reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
Glenmede Trust sold 5,069 Prothena Corp shares in Q3 2023, an estimated $246K.
Glenmede Trust first reported a position in Prothena Corp in Q2 2013 and held it in 16 quarters.
Glenmede Trust's Prothena Corp position peaked at $675K in Q4 2015.
186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.